文献速递肺外科

复发性结直肠癌肺转移的再次手术能否改善生存?

Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival?
PubMed 文献 · Ann Thorac Surg · 2018-03-30

这项多中心回顾性研究分析了203例接受肺转移切除术的结直肠癌肺转移患者,其中92例(45.3%)因肿瘤复发接受再次转移切除术,11例(5.4%)因第二次复发接受第三次转移切除术。首次转移切除术后的1年、3年和5年总生存率分别为97%、60%和34%,单次与再次转移切除术的总生存无显著差异(p=0.659)。Cox回归显示淋巴结状态(HR 17.7,p=0.008)和辅助化疗(HR 0.33,p=0.026)分别是总生存的危险因素和保护因素。

要点

  • 单次与再次肺转移切除术的总生存无显著差异(p=0.659)。
  • 淋巴结状态是总生存的危险因素(HR 17.7,p=0.008)。
  • 辅助化疗是总生存的保护因素(HR 0.33,p=0.026)。

核心结论

  • 对于转移性结直肠癌患者,应提供再次肺转移切除术,因为单次与再次转移切除术患者的总生存无差异。
  • 对于转移性结直肠癌,应建议辅助化疗。

研究设计与样本

  • 多中心回顾性研究,纳入203例接受转移切除术的结直肠癌肺转移患者。
  • 92例(45.3%)肿瘤复发患者接受再次转移切除术,11例(5.4%)因第二次复发接受第三次转移切除术。
  • 评估人口学和临床数据,包括原发肿瘤组织学分级、结直肠癌肝转移情况、原发肿瘤切除类型、肺转移灶数目、大小、位置和切除类型。
  • 分析总生存和无病生存,采用Cox回归模型识别影响总生存的变量。

主要发现

  • 173例(85.2%)接受楔形切除,21例(10.3%)接受肺叶切除,9例(4.4%)接受其他术式(全肺切除、双肺叶切除)。
  • 平均随访39个月(范围7至154个月)。
  • 自结直肠癌诊断起的1年、3年和5年总体总生存率分别为99%、80%和60%;自首次转移切除术起分别为97%、60%和34%。
  • 单次与再次转移切除术的总生存log-rank检验无显著差异(p=0.659)。
  • Cox回归模型显示淋巴结状态(HR 17.7,p=0.008)和辅助化疗(HR 0.33,p=0.026)分别是总生存的危险因素和保护因素。

临床怎么用

  • 作者认为,对于转移性结直肠癌患者应提供再次肺转移切除术,因为单次与再次转移切除术的总生存无差异。
  • 作者建议,对于转移性结直肠癌应建议辅助化疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lung metastases occur in 10% to 20% of patients with colorectal cancer (CRC). Lung metastatic pathways of CRC are poorly known, and the optimal management for recurrent lung metastases remains uncertain. METHODS: Long-term oncologic outcomes of 203 patients with CRC lung metastases who underwent metastasectomy were investigated in this multicenter retrospective study. Ninety-two patients (45.3%) with tumor relapse underwent repeated metastasectomy and 11 (5.4%) received a third metastasectomy for a second relapse. Demographic and clinical data, including histologic grade of primary tumor, presence of CRC liver metastases, type of primary tumor resection, number, size, location, and resection type of pulmonary metastases, were evaluated. Overall survival (OS) and disease-free survival were analyzed. Cox regression model was performed to identify variables that influenced OS. RESULTS: One hundred seventy-three patients (85.2%) received a wedge resection, 21 (10.3%) underwent pulmonary lobectomy, and 9 (4.4%) underwent other procedures (pneumonectomy, bilobectomy). The mean follow-up was 39 months (range: 7 to 154 months). One-, 3-, and 5-year global OS from CRC diagnosis was 99%, 80%, and 60%, respectively, and 97%, 60%, and 34% from the first metastasectomy, respectively. Log-rank test between OS (one versus repeated metastasectomy) did not show significant differences (p = 0.659). Cox regression model showed that nodal status (hazard ratio [HR] 17.7, p = 0.008) and administration of adjuvant chemotherapy (HR 0.33, p = 0.026) are risk and protective factors, respectively, for OS. CONCLUSIONS: Repeated pulmonary metastasectomy should be offered to patients with metastatic CRC because there are no differences in terms of OS between patients undergoing single and repeated metastasectomy. Adjuvant chemotherapy should be suggested in case of metastatic CRC.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Menna C, Berardi G, Tierno SM, et al. Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival? Ann Thorac Surg. 2018. PMID: 29605599. doi:10.1016/j.athoracsur.2018.02.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。